55.34MMarket Cap-288P/E (TTM)
3.305High3.181Low286.43KVolume3.300Open3.270Pre Close937.61KTurnover1.91%Turnover RatioLossP/E (Static)16.92MShares57.20052wk High0.24P/B49.13MFloat Cap2.88052wk Low--Dividend TTM15.03MShs Float57.200Historical High--Div YieldTTM3.79%Amplitude2.880Historical Low3.273Avg Price1Lot Size
Mural Oncology Stock Forum
NEWS
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Mural Oncology presented data from its ARTISTRY-3 trial at the ASCO annual meeting, showing that less frequent dosing of nemvaleukin alfa (nemvaleukin), an engineered IL-2 cytokine, is well-tolerated and effective.
The trial shifted from five daily infusions to two infusions per three-week cycle, both as a single agent and in combination with pembrolizu...
NEWS
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
👃
👄
$Mural Oncology(MURA.US)$
No comment yet